GSK
718 hedge funds and large institutions have $8.72B invested in GSK in 2015 Q4 according to their latest regulatory filings, with 93 funds opening new positions, 233 increasing their positions, 274 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
718
Holders Change
+12
Holders Change %
+1.7%
% of All Funds
18.86%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.26%
New
93
Increased
233
Reduced
274
Closed
69
Calls
$221M
Puts
$120M
Net Calls
+$102M
Net Calls Change
+$34.8M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$553M |
| 2 |
2
Jane Street
New York
|
$86.3M |
| 3 |
3
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$473M |
| 4 |
JHC
4
JFB Holdings Corp
Atlanta,
Georgia
|
$96.2M |
| 5 |
5
Citigroup
New York
|
$36.8M |
Top Sellers
| 1 |
1
Arrowstreet Capital
Boston,
Massachusetts
|
$3.07M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$505M |
| 3 |
3
Renaissance Technologies
New York
|
$7.12M |
| 4 |
4
Federated Hermes
Pittsburgh,
Pennsylvania
|
$249M |
| 5 |
O
5
OppenheimerFunds
New York
|
$26M |
